Monday, 26 January 2009

Clinical Research Study Now Enrolling People with

While Parkinson's disease is recognized for its profound effects on movement such as tremors, less known is that 1 in 3 Parkinson's disease patients will develop changes that include hallucinations, illusions and delusions. According to Arcadia Pharmaceuticals "As Parkinson's disease progresses, up to 40 percent of patients can experience what is called 'Parkinson's Psychosis.' A condition in which patients experience changes in thought, behavior and judgment that can have devastating effects. In more advanced stages these symptoms include hallucinations, illusions and delusions where patients see things that aren't really there, believe things that are untrue, create false ideas and falsely accuse those closest to them." Arcadia, with sponsorship from the Michael J Fox Foundation is sponsoring a study aimed at improving the quality of life for people with Parkinson's disease and its behavioral complications. More details of the study and how to enrol are available at www.ParkinsonsMindStudy.com

1 comments:

Anonymous said...

Please confirm - is this article about "ACADIA" Pharmaceuticals, rather than "Arcadia Pharmaceuticals"?